Which has the lower trailing P/E, ABBV or PFE?

PFE has the lower trailing P/E: ABBV trades at 129.20 and PFE at 19.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or PFE?

Over the past five years, PFE grew revenue faster — ABBV at a 4.59% CAGR versus PFE at 8.22%.

Does ABBV or PFE pay a bigger dividend?

ABBV yields 2.56% and PFE yields 6.81% based on trailing dividends and the latest price.

Is ABBV or PFE more profitable?

PFE runs the higher net margin — ABBV at 5.79% versus PFE at 11.83%.

How have ABBV and PFE total returns compared?

Over the past 10 years, ABBV delivered 19.90% and PFE delivered 1.54% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Pfizer Inc. (PFE)

A side-by-side comparison of AbbVie Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$469.44B

$265.70HealthcareDelayed quote: Jul 29, 2026, 2:10 PM EDT

PFE

Pfizer Inc.

$143.14B

$25.12HealthcareDelayed quote: Jul 29, 2026, 2:10 PM EDT

Total return — ABBV vs PFE

growth of $100 · dividends reinvested · last 14y

ABBV +1197.1%PFE +90.5%ABBV compounded faster

Log scale — wide-divergence pair

ABBV PFE

ABBV vs PFE: by the numbers

•ABBV is the larger company ($469.44B vs $143.14B market cap).
•PFE trades at the lower trailing earnings multiple (19.27 vs 129.20 P/E), one valuation lens rather than an overall verdict.
•PFE converts more revenue to profit (11.83% vs 5.79% net margin).
•PFE grew revenue faster over the past five years (8.22% vs 4.59% CAGR).
•PFE pays the higher dividend yield (6.81% vs 2.56%).

Metrics side by side

Valuation

Metric	ABBV	PFE
P/E ratio	129.20	19.27
Forward P/E	N/A	8.58
P/S ratio	7.44	2.29
P/B ratio	17.00	1.61
EV / EBITDA	20.92	9.88
FCF yield	4.46%	6.55%

Profitability

Metric	ABBV	PFE
Gross margin	70.68%	69.35%
Operating margin	27.60%	23.45%
Net margin	5.79%	11.83%
ROE	13.23%	8.31%
ROIC	12.97%	8.84%

Dividends

Metric	ABBV	PFE
Dividend yield	2.56%	6.81%
Payout ratio	284.39%	126.47%

Growth (annualized)

Metric	ABBV	PFE
Revenue CAGR (5Y)	4.59%	8.22%
EPS CAGR (5Y)	-2.79%	-3.78%
FCF CAGR (5Y)	3.24%	-3.79%
Total return CAGR (5Y)	21.73%	-5.22%

Frequently asked

Which has the lower trailing P/E, ABBV or PFE?: PFE has the lower trailing P/E: ABBV trades at 129.20 and PFE at 19.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or PFE?: Over the past five years, PFE grew revenue faster — ABBV at a 4.59% CAGR versus PFE at 8.22%.
Does ABBV or PFE pay a bigger dividend?: ABBV yields 2.56% and PFE yields 6.81% based on trailing dividends and the latest price.
Is ABBV or PFE more profitable?: PFE runs the higher net margin — ABBV at 5.79% versus PFE at 11.83%.
How have ABBV and PFE total returns compared?: Over the past 10 years, ABBV delivered 19.90% and PFE delivered 1.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Pfizer P/E ratio AbbVie dividend yield Pfizer dividend yield AbbVie ROE Pfizer ROE AbbVie operating margin Pfizer operating margin AbbVie revenue growth Pfizer revenue growth AbbVie free cash flow Pfizer free cash flow

AbbVie & Pfizer appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.